Publicacions en col·laboració amb investigadors/es de Universidad de Granada (15)

2023

  1. Abrogation of stemness in osteosarcoma by the mithramycin analog EC-8042 is mediated by its ability to inhibit NOTCH-1 signaling

    Biomedicine and Pharmacotherapy, Vol. 162

2020

  1. GARP promotes the proliferation and therapeutic resistance of bone sarcoma cancer cells through the activation of TGF-β

    Cell Death and Disease, Vol. 11, Núm. 11

2014

  1. Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells

    Stem Cells, Vol. 32, Núm. 5, pp. 1136-1148

2013

  1. Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation

    Stem Cells, Vol. 31, Núm. 10, pp. 2061-2072

  2. The differentiation stage of p53-Rb-deficient bone marrow mesenchymal stem cells imposes the phenotype of in vivo sarcoma development

    Oncogene, Vol. 32, Núm. 41, pp. 4970-4980

2012

  1. Modeling sarcomagenesis using multipotent mesenchymal stem cells

    Cell Research, Vol. 22, Núm. 1, pp. 62-77

  2. Multipotent mesenchymal stromal cells: Clinical applications and cancer modeling

    Advances in Experimental Medicine and Biology, Vol. 741, pp. 187-205

  3. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors

    PLoS ONE, Vol. 7, Núm. 4

2011

  1. Circulating cancer cells in division in an early breast cancer patient

    Annals of Oncology

  2. FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells

    Stem Cells, Vol. 29, Núm. 2, pp. 179-192

  3. Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement

    Leukemia, Vol. 25, Núm. 3, pp. 400-410

2010

  1. Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo

    Cancer Research, Vol. 70, Núm. 10, pp. 4185-4194

2009

  1. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene

    Journal of Experimental Medicine, Vol. 206, Núm. 13, pp. 3131-3141

  2. Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells1 2 www.neoplasia.com

    Neoplasia, Vol. 11, Núm. 4, pp. 397-407

2008

  1. Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 6B, pp. 2552-2565